Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy have?
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy has 331 citations in the OpenAlex counts ScholarIQ stores.
When was Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy published?
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy has 2024 year in the ScholarIQ index.
What is the open-access status of Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy?
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy has hybrid oa status in the ScholarIQ index.
What is the DOI of Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy?
The DOI for Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy is on the source record.
What is the PMID of Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy?
The PMID for Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy is on the source record.
What is the OpenAlex record for Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy?
The OpenAlex for Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy is on the source record.